HOME >> BIOLOGY >> NEWS
Extended-release niacin effective in low doses for diabetics, say UT Southwestern researchers

DALLAS July 22, 2002 Niacin, a medication once discouraged for the treatment of lipid abnormalities in patients with diabetes, has the potential ability, when given in low doses, to be well-tolerated and effective, according to UT Southwestern Medical Center at Dallas researchers, who led the multicenter trial.

The researchers report in today's issue of Archives of Internal Medicine that in the 148 study participants extended-release niacin (Niaspan) led to significantly improved lipid levels and minimal changes in glycemic control.

"Previous reports have shown that niacin in high doses raises blood glucose, but this trial shows that in doses of 1,000 milligrams per day and 1,500 mg/d, niacin therapy was well-tolerated and changes in glycemic control were minimal," said Dr. Scott Grundy, the study's lead author, director of the Center for Human Nutrition at UT Southwestern and holder of the Distinguished Chair in Human Nutrition. "Low doses of an extended form of niacin also had favorable effects on blood lipids and lipoproteins."

The researchers targeted niacin therapy for a condition in patients with diabetes called dyslipidemia, which is characterized by high levels of triglycerides and other lipid-related abnormalities along with depressed levels of the healthier high-density lipoprotein (HDL) cholesterol.

"Niacin therapy has been discouraged by clinicians because high doses can worsen glycemic control in patients with diabetes," said Dr. Gloria Vega, a professor of clinical nutrition and a study co-author. "In this study we evaluated the tolerance and effectiveness of niacin at low doses. This extended-release form is designed to circumvent the bothersome side effects of regular niacin, such as flushing of the skin."

During the trial, the study participants were divided into three groups. They received either 1,500 mg/d of extended-release niacin, 1,000 mg/d of extended-release niacin, or a placebo. About h
'"/>

Contact: Amy Shields
Amy.Shields@UTSouthwestern.edu
214-648-3404
UT Southwestern Medical Center
21-Jul-2002


Page: 1 2

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Endurance exercise found to be equally effective as diuretics in improving cardiac health
3. Purdue yeast makes ethanol from agricultural waste more effectively
4. Scientists learn how adjuvant makes vaccines effective
5. Super-effective jumping gene created
6. Drug combo effective in advanced breast cancer
7. Data show investigational antibiotic safe, effective in preventing travelers diarrhea
8. Mexican farmers effectively cultivate phenotypic diversity in maize
9. Newer drugs more effective at curing strep throat than penicillin
10. Researchers show chronic sinusitis is immune disorder; antifungal medicine effective treatment
11. Ribozyme package effective against hepatitis B virus

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... 30, 2020 , ... BioFactura, Inc. today announced a $1 ... Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense ... highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
(Date:7/18/2020)... ... , ... Commercial launch readiness is a critical stage in a product life ... vaccine, the global economic downturn will only increase price pressures overall for the industry. ... full value from every product launch is critical. However, history shows that only a ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... The ... centers in 16 countries, has reached its 20th anniversary of worldwide use. Introduced ... use at top universities including University of Pennsylvania, University of Michigan, University of ...
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said Matt ... the market and we were pleased that the IFT jury recognized that.” reFRESH™ couples ... a natural way to extend the shelf life and improve the safety of perishable ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/7/2020)... ... 2020 , ... Bio-IT World has announced the winners of ... University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were ... outstanding examples of how technology innovations and strategic initiatives can be powerful forces ...
Breaking Biology Technology:
Cached News: